BridgeMD
New treatment option for Endometrial Cancer
Official title Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer
ClinicalTrials.gov ID: NCT06870903
What this study is testing
- What it's testing
- The aim of this study is to compare two types of lymphadenectomy (transperitoneal vs. paracervical) during the lymphadenectomy phase of endometrial cancer staging surgery performed using V-NOTES, a new and advanced technique.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85, women only
You may be able to join if
- Patient Selection and Data Collection This study will be implemented in a single institution, Diyarbakır Gazi Yaşargil Training and Research...
- Participants whose endometrial biopsy resulted in endometrial cancer and whose disease will be detected limited to the uterus using imaging...
- Absence of synchronous malignancies.
- No neoadjuvant treatment before surgical intervention.
You likely can't join if
- will include:
- Contraindications to using methylene blue dye or contraindications to the vNOTES procedure.
- Patients who have had previous malignancy surgery.
- Severe, deeply penetrating endometriosis or enlarged uterus that may require forced vaginal extraction
- Receiving neodajuvant therapy
The study team makes the final eligibility decision.
Where it's taking place
- Diyarbakır, Baglar, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Diyarbakır, Baglar, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.